Association of single nucleotide polymorphisms in the thrombopoietin-receptor gene, but not the thrombopoietin gene, with differences in platelet count.

Abstract:

:Little is known about the mechanisms explaining the wide variation in platelet counts (PLT) and other hematologic parameters in humans. We previously showed that the sex-based difference in hematocrit was associated with nucleotide variation in the erythropoietin receptor gene (EPOR). We sought to identify new polymorphisms of the human thrombopoietin (TPO) and thrombopoietin receptor (TPOR) genes to determine any associations with blood PLT counts. We screened TPO and TPOR for polymorphisms using single-strand conformation polymorphism (SSCP) and DNA sequencing. Association of polymorphisms was studied in 304 normal subjects with low or high PLT counts. Distribution of allelic frequency was analyzed by the Chi-square statistic. Single nucleotide polymorphisms (SNPs) with two alleles were found in TPO and TPOR. The TPO SNP was a G to A transition at nucleotide 5753, and the TPOR SNP was a C to A transversion at position 550 in the 5'-promoter area. The allelic frequencies were 0.54 for G and 0.46 for A of TPO, and 0.62 for C and 0.38 for A of TPOR in a Caucasian population. The frequency of the TPOR allele "C" was significantly higher in subjects with high PLT count (>258 k/mm3) versus low PLT count (<224 k/mm3) and in males with high PLT count (>258 k/mm3) versus males with low PLT count (<212 k/mm3). In contrast, the frequency of the TPO alleles was not related to blood PLT counts. An association of TPO and TPOR allele distribution to red and white blood cell parameters was seen. These new SNPs found for the human TPO and TPOR genes help explain variations in blood PLT counts and may be useful in patient studies related to the roles of TPO and/or TPOR in disease.

journal_name

Am J Hematol

authors

Zeng SM,Murray JC,Widness JA,Strauss RG,Yankowitz J

doi

10.1002/ajh.20095

keywords:

subject

Has Abstract

pub_date

2004-09-01 00:00:00

pages

12-21

issue

1

eissn

0361-8609

issn

1096-8652

journal_volume

77

pub_type

杂志文章
  • Biosimilar epoetins and other "follow-on" biologics: update on the European experiences.

    abstract::After the patents of biopharmaceuticals have expired, based on specific regulatory approval pathways copied products ("biosimilars" or "follow-on biologics") have been launched in the EU. This article summarizes experiences with hematopoietic medicines, namely the epoetins (two biosimilars traded under five different ...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.21805

    authors: Jelkmann W

    更新日期:2010-10-01 00:00:00

  • C/EBPA gene mutation and C/EBPA promoter hypermethylation in acute myeloid leukemia with normal cytogenetics.

    abstract::In the current study, we investigated C/EBPA gene mutations and promoter hypermethylation in a series of 53 patients with CN-AML. In addition, we also analyzed two other frequent mutations (FLT3/ITD and NPM1) in these patients and correlated them with C/EBPA gene alterations. 13/53 patients were FLT3/ITD+/NPM1-, 11/53...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21706

    authors: Lu Y,Chen W,Chen W,Stein A,Weiss LM,Huang Q

    更新日期:2010-06-01 00:00:00

  • Second round robin for plasma hepcidin methods: first steps toward harmonization.

    abstract::Measurements of the iron regulatory hormone hepcidin by various methodologies and laboratories are not harmonized. As a result different numeric results are obtained for the same clinical sample. We investigated whether better agreement between plasma hepcidin methods can be achieved by harmonization. Native plasma po...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.23289

    authors: Kroot JJ,van Herwaarden AE,Tjalsma H,Jansen RT,Hendriks JC,Swinkels DW

    更新日期:2012-10-01 00:00:00

  • Severe acute thrombocytopenia following infusion of plasma containing anti P1A1.

    abstract::An 18-year-old girl with a preoperative platelet count of 216,000/cmm received 3 units of stored plasma at the time of surgery. Within 6 hours her platelet count had fallen to 5,000/mm3 and hemorrhagic manifestations appeared. One of the plasma donors was found to be P1A1 negative with an anti P1A1 antibody. The recip...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830250213

    authors: Nijjar TS,Bonacosa IA,Israels LG

    更新日期:1987-06-01 00:00:00

  • Idiopathic immune-mediated acquired von Willebrand's disease in a patient with angiodysplasia: demonstration of an unusual inhibitor causing a functional defect and rapid clearance of von Willebrand factor.

    abstract::A case of idiopathic immune-mediated von Willebrand's disease (AvWD) associated angiodysplasia and recurrent lower gastrointestinal bleeding is reported. Coagulation parameters at presentation were activated partial thromboplastin time of 41 sec, bleeding time >15 min, factor VIII procoagulant activity, 5%; von Willeb...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199902)60:2<151::aid-ajh13

    authors: Alhumood SA,Devine DV,Lawson L,Nantel SH,Carter CJ

    更新日期:1999-02-01 00:00:00

  • Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO© ).

    abstract::This study demonstrates the quantitative characteristics of the first patient-reported outcome (PRO) tool developed for patients with nontransfusion-dependent β-thalassemia (NTDT), the NTDT-PRO© . A multicenter validation study was performed over 24 weeks, involving 48 patients from Italy, Lebanon, Greece, and Thailan...

    journal_title:American journal of hematology

    pub_type: 杂志文章,多中心研究

    doi:10.1002/ajh.25344

    authors: Taher A,Cappellini MD,Viprakasit V,Sutcharitchan P,Mahmoud D,Laadem A,Khan A,Gwaltney C,Harding G,Attie K,Zhang X,Zou J,Pariseau J,Henry Hu X,Kattamis A

    更新日期:2019-02-01 00:00:00

  • Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia.

    abstract::Antithymocyte globulins (ATG) plus cyclosporine (CSA) is the gold standard immunosuppressive treatment (IST) for patients with aplastic anemia. A prospective randomized trial showed in 2011 that hATG was superior to rabbit ATG for first-line treatment of severe AA. The French Health Agency (ANSM) permitted a patient-n...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.25050

    authors: Peffault de Latour R,Tabrizi R,Marcais A,Leblanc T,Lamy T,Mohty M,Tavitian S,Jubert C,Pasquet M,Galambrun C,Nguyen S,Cahn JY,Braun T,Deconinck E,Bay JO,Sicre de Fontbrune F,Barraco F,Socié G

    更新日期:2018-05-01 00:00:00

  • Significance and limits of cerebrospinal fluid beta-2-microglobulin measurement in course of acute lymphoblastic leukemia.

    abstract::Cerebrospinal fluid beta-2-microglobulin (CSF-beta 2m) was measured longitudinally in 48 patients affected by acute lymphoblastic leukemia (ALL). Thirteen developed a central nervous system (CNS) involvement during the course of the disease; although moderately higher mean CSF-beta 2m levels were found in these subjec...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830280402

    authors: Musto P,Tomasi P,Cascavilla N,Ladogana S,La Sala A,Melillo L,Nobile M,Castoldi G,Carotenuto M

    更新日期:1988-08-01 00:00:00

  • HLA-DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantation.

    abstract::Matching for HLA-A, -B, -C, and -DRB1 loci (8/8 match) is currently the gold standard for unrelated donor hematopoietic cell transplantation (HCT). In Europe, patients are also matched at the HLA-DQB1 loci (10/10 match). However, there is increasing evidence that matching at HLA-DRB3/4/5 loci may help to lower transpl...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.25133

    authors: Ducreux S,Dubois V,Amokrane K,Yakoub-Agha I,Labalette M,Michallet M,Rubio MT,Kennel A,Forcade E,Lafarge X,Bulabois CE,Masson D,Daguindau E,Devys A,Moalic V,Quelvennec E,Boudifa A,Picard C,Van Endert P,de Matteis M,

    更新日期:2018-05-04 00:00:00

  • Superficial venous thrombosis associated with congenital absence of the inferior vena cava and previous episode of deep venous thrombosis.

    abstract::Congenital malformations of the inferior vena cava (IVC) are uncommon and may be associated with an increased risk of venous thrombosis. We report the case of a man with congenital absence of the IVC and remote history of deep venous thrombosis who now presents with severe abdominal wall superficial thrombophlebitis. ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21089

    authors: Evanchuk DM,Von Gehr A,Zehnder JL

    更新日期:2008-03-01 00:00:00

  • Acute myeloid leukemia: 2016 Update on risk-stratification and management.

    abstract::Evidence suggest that even patients aged 70 or above benefit from specific AML therapy. The fundamental decision in AML then becomes whether to recommend standard or investigational treatment. This decision must rest on the likely outcome of standard treatment. Hence we review factors that predict treatment related mo...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.24439

    authors: Estey E

    更新日期:2016-08-01 00:00:00

  • Overwhelming postsplenectomy infection.

    abstract::One of the more intriguing aspects of the spleen is the protection against certain bacterial infections afforded by its unique vascular and immune function. There have been extensive clinical surveys which indicate an incidence of overwhelming postsplenectomy infection (OPSI) above that of the disease for which the sp...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830020210

    authors: Krivit W

    更新日期:1977-01-01 00:00:00

  • Stomatocytic transformation of red blood cells after marathon running.

    abstract::We studied red blood cell morphology in two marathon runners before, immediately after, and 1 day after a marathon race. A discocyte-stomatocyte transformation was found by light microscopy of wet preparations and also by scanning electron microscopy, with about one-half the erythrocytes becoming cup-shaped after the ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830190213

    authors: Reinhart WH,Chien S

    更新日期:1985-06-01 00:00:00

  • Inhibition of the activation of hageman factor (factor XII) by eosinophils and eosinophilic constituents.

    abstract::Several syndromes characterized by striking eosinophilia may be complicated by thrombosis. The experiments described indicate that, paradoxically, eosinophils and certain of their constituents inhibit the activation of Hageman factor (HF, factor XII). In earlier studies, suspensions of mixed types of granulocytes, oth...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830420127

    authors: Ratnoff OD,Gleich GJ,Shurin SB,Kazura J,Everson B,Embury P

    更新日期:1993-01-01 00:00:00

  • A concise review: iron absorption--the mucin-mobilferrin-integrin pathway. A competitive pathway for metal absorption.

    abstract::Newly identified iron binding proteins isolated from rat duodenal homogenates permit better understanding of iron absorption. Mucins bind iron at acid pH to keep iron soluble and available for absorption at the more alkaline pH of the duodenum; this explains iron deficiency following prolonged achlorhydria. Integrin (...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.2830420114

    authors: Conrad ME,Umbreit JN

    更新日期:1993-01-01 00:00:00

  • Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies.

    abstract::With the emerging success of treating CD19 expressing B cell malignancies with ex vivo modified, autologous T cells that express CD19-directed chimeric antigen receptors (CAR), there is intense interest in expanding this evolving technology to develop effective modalities to treat other malignancies including solid tu...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.24794

    authors: Perera LP,Zhang M,Nakagawa M,Petrus MN,Maeda M,Kadin ME,Waldmann TA,Perera PY

    更新日期:2017-09-01 00:00:00

  • Neutropenia in the age of genetic testing: Advances and challenges.

    abstract::Identification of genetic causes of neutropenia informs precision medicine approaches to medical management and treatment. Accurate diagnosis of genetic neutropenia disorders informs treatment options, enables risk stratification, cancer surveillance, and attention to associated medical complications. The rapidly expa...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.25374

    authors: Furutani E,Newburger PE,Shimamura A

    更新日期:2019-03-01 00:00:00

  • A novel alpha-thalassemia-2 (-2.7-kb) observed in a Chinese patient with Hb H disease.

    abstract::We describe a newly detected alpha-thalassemia-2 (alpha-thal-2) deletion characterized by a small -2.7-kb deletion involving the alpha 1 globin gene. This deletion has thus far been observed in only one Chinese subject with Hb H disease. ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830380321

    authors: Zhao JB,Zhao L,Fei YJ,Liu JC,Huisman TH

    更新日期:1991-11-01 00:00:00

  • Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients.

    abstract::Systemic light-chain (AL) amyloidosis may be associated with acquired factor X (FX) deficiency and optimal management of this coagulopathy is unknown. We reviewed our experience with 60 patients with isolated FX deficiency (< or =50%) due to AL amyloidosis that underwent an invasive procedure between 1975 and 2007. Th...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21603

    authors: Thompson CA,Kyle R,Gertz M,Heit J,Pruthi R,Pardanani A

    更新日期:2010-03-01 00:00:00

  • Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.

    abstract::Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with isolated thrombocytopenia and hemorrhagic risk. While many children with ITP can be safely observed, treatments are often needed for various reasons, including to decrease bleeding, or to improve health related quality of life (HRQoL). There are a n...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/ajh.25479

    authors: Grace RF,Shimano KA,Bhat R,Neunert C,Bussel JB,Klaassen RJ,Lambert MP,Rothman JA,Breakey VR,Hege K,Bennett CM,Rose MJ,Haley KM,Buchanan GR,Geddis A,Lorenzana A,Jeng M,Pastore YD,Crary SE,Neier M,Neufeld EJ,Neu N

    更新日期:2019-07-01 00:00:00

  • First report of a B cell lymphoproliferative disorder arising in a patient treated with immune suppressants for severe aplastic anemia.

    abstract::Aplastic anemia is a disorder characterized by pancytopenia and bone marrow hypocellularity. There is some evidence that aplastic anemia may be due to suppression of hematopoiesis by activated T-suppressor cells. Thus, immunosuppressive agents have been used as an alternative to bone marrow transplantation for treatme...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(SICI)1096-8652(199606)52:2<108::AID-AJH7>

    authors: Dorr V,Doolittle G,Woodroof J

    更新日期:1996-06-01 00:00:00

  • Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia.

    abstract::Clofarabine has shown activity and tolerability in older patients with acute myeloid leukemia (AML). We investigated the safety and tolerability of an oral formulation of clofarabine for consolidation therapy of patients aged 60 and older with AML. In this phase I study, twenty-two patients older than 60 years with AM...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.23663

    authors: Jacoby MA,Martin MG,Uy GL,Westervelt P,Dipersio JF,Cashen A,Stockerl-Goldstein K,Vij R,Luo J,Reineck T,Bernabe N,Abboud CN

    更新日期:2014-05-01 00:00:00

  • Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma.

    abstract::Zoledronic acid (ZOL), an intravenous bisphosphonate, has been shown to reduce and delay the incidence of skeletal-related events (SREs) in multiple myeloma (MM) patients with bone disease. A retrospective claims-based analysis was conducted that used two distinct US managed care databases to examine the relationship ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.23164

    authors: Henk HJ,Teitelbaum A,Perez JR,Kaura S

    更新日期:2012-05-01 00:00:00

  • CD5 positive immunoregulatory B cells in spleen populations from multiple myeloma patients.

    abstract::CD19+CD5+ lymphocytes constitute a minority of peripheral blood B cells. In view of the importance of these cells in the pathogenesis of the immunoregulation of myeloma, their incidence in another lymphoid organ was determined. CD5+ B cells were studied in 9 spleens from patients with multiple myeloma and in 10 spleen...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830370306

    authors: MacKenzie MR,Paglieroni T,Caggiano V

    更新日期:1991-07-01 00:00:00

  • Isolation and characterization of granulocyte lysosomal proteins and study of their effects on the clotting system.

    abstract::Lysosomes (granules) of rabbit PMN leukocytes were extracted with either HCl or H2SO4, and the extracts were chromatographed over Sephadex to separate protein constituents. Some of the low molecular weight cationic proteins homogeneous on SDS PAGE (8% and 12.5% gels) were characterized by electrophoretic mobility in a...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830070309

    authors: Herion JC,Bucher JR,Penniall R,Walker RI,Baker M,Roberts HR

    更新日期:1979-01-01 00:00:00

  • Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut.

    abstract::In light of the relationship between immune system dysregulation and multiple myeloma (MM) risk, we investigated whether genetic variation in 92 immune function genes among 77 gene regions are associated with MM susceptibility in a population-based case-control study (108 cases and 482 controls) conducted among Caucas...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21760

    authors: Lee KM,Baris D,Zhang Y,Hosgood HD 3rd,Menashe I,Yeager M,Zahm SH,Wang SS,Purdue MP,Chanock S,Zheng T,Rothman N,Lan Q

    更新日期:2010-08-01 00:00:00

  • Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: Data from 151 patients.

    abstract::FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia (F/P+ MN-eo) is a rare disease: robust epidemiological data are lacking and reported issues are scarce, of low sample-size and limited follow-up. Imatinib mesylate (IM) is highly efficient but no predictive factor of relapse after discontinuation has yet been i...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/ajh.25945

    authors: Rohmer J,Couteau-Chardon A,Trichereau J,Panel K,Gesquiere C,Ben Abdelali R,Bidet A,Bladé JS,Cayuela JM,Cony-Makhoul P,Cottin V,Delabesse E,Ebbo M,Fain O,Flandrin P,Galicier L,Godon C,Grardel N,Guffroy A,Hamidou M,

    更新日期:2020-11-01 00:00:00

  • T-cell non-Hodgkin lymphoma in human immunodeficiency virus-1-infected individuals.

    abstract::We present two patients with human immunodeficiency virus-1 (HIV-1) infection in whom T-cell non-Hodgkin lymphoma developed, based on pathologic diagnosis, immunophenotyping, and T-cell receptor gene rearrangement. Both cases were positive for human immunodeficiency virus-1 by enzyme-linked immunosorbent assay and imm...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830310307

    authors: Lust JA,Banks PM,Hooper WC,Paya CV,Kueck BD,Hanson GA,Ritch PS,Woloschak GE

    更新日期:1989-07-01 00:00:00

  • Tumor necrosis factor-alpha overproduction in Fanconi's anemia.

    abstract::Various in vitro studies and clinical observations suggest that Fanconi's anemia (FA) patients are unable to detoxify adequately superoxide anions (O2-) released by activated phagocytes. Recent studies have shown that certain lymphokines such as tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830420211

    authors: Schultz JC,Shahidi NT

    更新日期:1993-02-01 00:00:00

  • Familial type II protein C deficiency associated with warfarin-induced skin necrosis and bilateral adrenal hemorrhage.

    abstract::A family is described in which venous thromboembolic disease is associated with reduced plasma protein C activity and normal levels of protein C antigen. Immunoelectrophoretic analysis of protein C antigen gave an abnormal pattern in all affected members, suggesting that the disorder is related to the presence of a st...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830290410

    authors: Conlan MG,Bridges A,Williams E,Marlar R

    更新日期:1988-12-01 00:00:00